 | Up a level |
2020
Matser, Y., Verly, I., De Sain-Van der Velden, M., Wieczorek, A., Vicha, A., Ash, S., Pasqualini, C., Beck-Popovic, M., Schleiermacher, G., Canete, A., Owens, C., Ora, I., De Wilde, B., Cangemi, G., Garaventa, A., Grouzmann, E., Papadakis, V., Simon, T., Hero, B., Van Kuilenburg, A. and Tytgat, G. (2020). Optimising Urinary Catecholamine Diagnostics for Neuroblastoma Patients. Pediatr. Blood Cancer, 67. S. S278 - 1. HOBOKEN: WILEY. ISSN 1545-5017
2014
London, W., Moroz, V., Hero, B., Park, J. R., Valteau-Couanet, D., Nakagawara, A., Berthold, F., Matthay, K. K., Schleiermacher, G. and Machin, D. (2014). A NEUROBLASTOMA RISK CLASSIFICATION MODEL FOR DEVELOPING COUNTRIES: A STUDY FROM THE INTERNATIONAL NEUROBLASTOMA (NB) RISK GROUP (INRG) DATABASE. Pediatr. Blood Cancer, 61. S. S119 - 1. HOBOKEN: WILEY-BLACKWELL. ISSN 1545-5017
2012
Schleiermacher, G., Mosseri, V., London, W. B., Maris, J. M., Brodeur, G. M., Attiyeh, E., Haber, M., Khan, J., Nakagawara, A., Speleman, F., Noguera, R., Tonini, G. P., Fischer, M., Ambros, I., Monclair, T., Matthay, K. K., Ambros, P., Cohn, S. L. and Pearson, A. D. J. (2012). Segmental chromosomal alterations have prognostic impact in neuroblastoma: a report from the INRG project. Br. J. Cancer, 107 (8). S. 1418 - 1423. LONDON: NATURE PUBLISHING GROUP. ISSN 0007-0920